Molina J-M, et al. Doravirine (DOR) versus ritonavir-boosted darunavir (DRV+r): 96-week results of the randomized, double-blind, phase 3 DRIVE-FORWARD Noninferiority trial. AIDS 2018.
Het 2020 GOLD Science Committee-rapport over COVID-19 en COPD
mrt 2021 | COPD, Pneumonie, Virale infecties